Direct Dirigeants by NewCap invites you to their event

Aelis Farma - Presentation of Phase 1/2 Clinical Results in the Treatment of Cognitive Disorders associated with Down syndrome

About this event

Following the release of the Phase 1/2 results for AEF0217 in Down syndrome, Aelis Farma is pleased to invite you to an interactive webinar on Tuesday, November 19, 2024, at 4:00 pm (CET) / 10:00 am (ET).

Pier Vincenzo Piazza, CEO and Stéphanie Monlezun, COO, will provide a detailed presentation of the clinical results obtained with AEF0217 in the treatment of cognitive disorders of Down syndrome and answer your questions.

Direct Dirigeants by NewCap

La plateforme d’échanges avec les dirigeants de sociétés cotées en bourse

NewCap a conçu une plateforme d’événements sur mesure pour créer, enrichir et pérenniser la relation entre les sociétés cotées et leurs actionnaires.